| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.002 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.002 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.004 |